Downloads
Downloads
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler
pdf,
52.57 KB ()
The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.
pdf,
191.66 KB ()
Navigating the Rise of Injectables, Quality Control Measures, and Personalization.
pdf,
105.60 KB
By Rahul Thakar, PhD, Technical Key Account Manager, Datwyler.
pdf,
184.44 KB